Literature DB >> 15167347

MRI follow-up and natural history of avascular necrosis of the femoral head in Kuwaiti children with sickle cell disease.

Renu Gupta1, Adekunle D Adekile.   

Abstract

PURPOSE: : To document the MRI progression and the natural history of avascular necrosis of the femoral head (AVNFH) in Arab children with sickle cell disease. PATIENTS AND METHODS: Twenty-three SS and 7 SbetaThal patients (aged 6-17 years) were screened for AVNFH between 1998 and 1999. Eight (26.7%) were identified with varying degrees of AVNFH. Seventeen of the original 30 patients have now been followed for 1 to 4 (mean 2.0 +/- 1.2) years, with repeat MRI of the hips. Spin-echo T1-and T2-weighted images and T2 fat-saturation sequences were obtained using a 1.5-Tesla GE unit with superconductors. AVNFH was graded I (mild), II (moderate), or III (severe).
RESULTS: Eleven (64.7%) of the 17 patients had significant progression of their lesions; at the initial study, 9 were normal, 7 were grade I, 1 was grade II, and none was grade III. At the end of the follow-up period, two were normal, seven were grade I, one was grade II, and seven were grade III. Of the nine who were initially normal, two still had no lesions, while four were grade I and three were grade III on follow-up. Of the seven who were classified as grade I initially, four remained at grade I, one moved to grade II, and two became grade III. The one patient who was initially grade II progressed to III.
CONCLUSIONS: AVNFH is a common, chronic, and unrelenting complication in children with sickle cell disease, and it is usually progressive.

Entities:  

Mesh:

Year:  2004        PMID: 15167347     DOI: 10.1097/00043426-200406000-00004

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  7 in total

Review 1.  Osteonecrosis in sickle cell disease: an update on risk factors, diagnosis, and management.

Authors:  Oyebimpe O Adesina; Lynne D Neumayr
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2019-12-06

2.  Evaluation of von Willebrand factor and ADAMTS-13 antigen and activity levels in sickle cell disease patients in Kuwait.

Authors:  Anwar Al-Awadhi; Adekunle Adekile; Rajaa Marouf
Journal:  J Thromb Thrombolysis       Date:  2017-01       Impact factor: 2.300

3.  Patients with sickle cell anemia on simple chronic transfusion protocol show sex differences for hemodynamic and hematologic responses to transfusion.

Authors:  Jon A Detterich; Suvimol Sangkatumvong; Roberta Kato; Ani Dongelyan; Adam Bush; Michael Khoo; Herbert J Meiselman; Thomas D Coates; John C Wood
Journal:  Transfusion       Date:  2012-11-26       Impact factor: 3.157

4.  Osteonecrosis in children after allogeneic hematopoietic cell transplantation: study of prevalence, risk factors and longitudinal changes using MR imaging.

Authors:  S Sharma; W-H Leung; P Deqing; J Yang; R Rochester; L Britton; M D Neel; K K Ness; S C Kaste
Journal:  Bone Marrow Transplant       Date:  2011-12-12       Impact factor: 5.483

Review 5.  Musculoskeletal Manifestations of Sickle Cell Disease: A Review.

Authors:  Raju Vaishya; Amit Kumar Agarwal; Edwin O Edomwonyi; Vipul Vijay
Journal:  Cureus       Date:  2015-10-20

Review 6.  The Genetic and Clinical Significance of Fetal Hemoglobin Expression in Sickle Cell Disease.

Authors:  Adekunle Adekile
Journal:  Med Princ Pract       Date:  2020-09-04       Impact factor: 1.927

7.  Management of osteonecrosis of the femoral head in children with sickle cell disease: results of conservative and operative treatments at skeletal maturity.

Authors:  C Mallet; A Abitan; C Vidal; L Holvoet; K Mazda; A-L Simon; B Ilharreborde
Journal:  J Child Orthop       Date:  2018-02-01       Impact factor: 1.548

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.